Loading clinical trials...
Loading clinical trials...
The objective of this post-market registry is to assess the clinical use of the Lifetech CeraFlex™ Closure System in a real-world and on-label fashion.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Lifetech Scientific (Shenzhen) Co., Ltd.
NCT06590467 · Heart Diseases, ASD - Atrial Septal Defect, and more
NCT06347276 · Thrombosis Cardiac, Atrial Septal Defect, and more
NCT06849635 · Atrial Septal Defect
NCT06700174 · Atrial Septal Defect (ASD)
NCT06631534 · Atrial Septal Defect (ASD), Dexmedetomidine, and more
Hospital Pequeno Príncipe
Curitiba
Universidade Federal do Ceará
Fortaleza
Santa Casa de Misericórdia de Porto Alegre
Porto Alegre
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions